US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist
  • 42.850
  • -1.210-2.75%
Close Aug 9 16:00 ET
  • 42.850
  • 0.0000.00%
Post 20:01 ET
2.10BMarket Cap13.60P/E (TTM)

Amphastar Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amphastar Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 7, 2024

Revenue(YoY)

182.39M

+25.17%
EPS(YoY)

0.73

+48.98%
Analyst Rating

Buy

Aug 8, 2024

Amphastar Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 197.760M--
--2024/Q3-- / 195.115M--
Aug 7, 20242024/Q2182.394M / 170.910M--
May 8, 20242024/Q1171.800M / 174.713M--
Feb 28, 20242023/Q4178.105M / 173.326M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 197.760M--
--2024/Q3-- / 195.115M--
Aug 7, 20242024/Q2182.394M / 170.910M--
May 8, 20242024/Q1171.800M / 174.713M--
Feb 28, 20242023/Q4178.105M / 173.326M--

Unlock Free Earnings Estimates

Amphastar Pharmaceuticals Earnings Reports

  • Amphastar Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 9 16:20 ET

  • Amphastar Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 10 15:05 ET

  • Amphastar Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 29 22:45 ET

  • Amphastar Pharmaceuticals: Q3 2023 Earnings Report

    Nov 8, 2023 16:24 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 8, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Cannabis & Hemp
    Cannabis & Hemp
    Intraday+0.09%